Giovanni Ravasi
Biographic Data
| ID | 7504478 |
|---|---|
| NAME | Giovanni Ravasi |
| GIVEN NAMES | Giovanni |
| FAMILY NAME | Ravasi |
| SIGNATURE | RAVASI G |
| AFFILIATIONS | TuBerculosis Vaccine Initiative |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Tuberculosis and HIV coinfection and related collaborative activities in Latin America and the Caribbean
Objective. To inform about the most recent epidemiological trends and integrated programmatic response to tuberculosis (TB) and HIV coinfection in Latin America and the Caribbean (LAC). Methods. A descriptive review analyzed the most relevant indicators on TB/HIV coinfection in 33 countries in LAC with a cross-sectional and time-trend approach. Data were obtained from publicly available databases and analyzed through simple proportions, weighted …
HIV, syphilis, and viral hepatitis among Latin American indigenous peoples and Afro-descendants
Progress and challenges in implementing HIV care and treatment policies in Latin America following the treatment 2.0 initiative
A relatively good level of progress was perceived in the recommendations related to optimization of ART regimens. Challenges remain on the improvement of recommendations related to health system strengthening and the promotion and support aimed at community-based organizations as part of the response to HIV/AIDS in Latin America. The JRMs are a useful mechanism for providing coherent technical support to guide countries in the pursuit of a compre…
Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean
By the end of 2010, Latin America and the Caribbean (LAC) achieved 63% antiretroviral treatment (ART) coverage. Measures to control HIV drug resistance (HIVDR) at the country level are recommended to maximize the efficacy and sustainability of ART programs. Since 2006, the Pan American Health Organization has supported implementation of the World Health Organization (WHO) strategy for HIVDR prevention and assessment through regional capacity-buil…
No prominent works on this page.
Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean
By the end of 2010, Latin America and the Caribbean (LAC) achieved 63% antiretroviral treatment (ART) coverage. Measures to control HIV drug resistance (HIVDR) at the country level are recommended to maximize the efficacy and sustainability of ART programs. Since 2006, the Pan American Health Organization has supported implementation of the World Health Organization (WHO) strategy for HIVDR prevention and assessment through regional capacity-buil…
Progress and challenges in implementing HIV care and treatment policies in Latin America following the treatment 2.0 initiative
A relatively good level of progress was perceived in the recommendations related to optimization of ART regimens. Challenges remain on the improvement of recommendations related to health system strengthening and the promotion and support aimed at community-based organizations as part of the response to HIV/AIDS in Latin America. The JRMs are a useful mechanism for providing coherent technical support to guide countries in the pursuit of a compre…
HIV, syphilis, and viral hepatitis among Latin American indigenous peoples and Afro-descendants
Tuberculosis and HIV coinfection and related collaborative activities in Latin America and the Caribbean
Objective. To inform about the most recent epidemiological trends and integrated programmatic response to tuberculosis (TB) and HIV coinfection in Latin America and the Caribbean (LAC). Methods. A descriptive review analyzed the most relevant indicators on TB/HIV coinfection in 33 countries in LAC with a cross-sectional and time-trend approach. Data were obtained from publicly available databases and analyzed through simple proportions, weighted …
Latin Americans (3 works) · Medicine (3 works) · Political science (3 works) · Antiretroviral therapy (2 works) · Economic growth (2 works) · Environmental health (2 works) · Family medicine (2 works) · HIV/AIDS Research and Interventions (2 works) · Human immunodeficiency virus (HIV (2 works) · Pneumocystis jirovecii pneumonia detection and treatment (2 works)